-
Functional Areas
- Audit and Investigations
-
Capacity development and transition, strengthening systems for health
- A Strategic Approach to Capacity Development
- Capacity Development and Transition - Lessons Learned
- Capacity development and Transition Planning Process
- Capacity Development and Transition
- Capacity Development Objectives and Transition Milestones
- Capacity Development Results - Evidence From Country Experiences
- Functional Capacities
- Interim Principal Recipient of Global Fund Grants
- Legal and Policy Enabling Environment
- Overview
- Resilience and Sustainability
- Transition
-
Financial Management
- CCM Funding
- Grant Closure
- Grant Implementation
- Grant-Making and Signing
- Grant Reporting
- Import duties and VAT / sales tax
- Overview
- Sub-recipient Management
-
Grant closure
- Overview
-
Steps of Grant Closure Process
- 1. Global Fund Notification Letter 'Guidance on Grant Closure'
- 2. Preparation and Submission of Grant Close-Out Plan and Budget
- 3. Global Fund Approval of Grant Close-Out Plan
- 4. Implementation of Close-Out Plan and Completion of Final Global Fund Requirements (Grant Closure Period)
- 5. Operational Closure of Project
- 6. Financial Closure of Project
- 7. Documentation of Grant Closure with Global Fund Grant Closure Letter
- Terminology and Scenarios for Grant Closure Process
- Human resources
- Human rights, key populations and gender
-
Legal Framework
- Agreements with Sub-recipients
- Agreements with Sub-sub-recipients
- Amending Legal Agreements
- Implementation Letters and Performance Letters
- Language of the Grant Agreement and other Legal Instruments
- Legal Framework for Other UNDP Support Roles
- Other Legal and Implementation Considerations
- Overview
- Project Document
- Signing Legal Agreements and Requests for Disbursement
-
The Grant Agreement
- Grant Confirmation: Conditions Precedent (CP)
- Grant Confirmation: Conditions
- Grant Confirmation: Face Sheet
- Grant Confirmation: Schedule 1, Integrated Grant Description
- Grant Confirmation: Schedule 1, Performance Framework
- Grant Confirmation: Schedule 1, Summary Budget
- Grant Confirmation: Special Conditions (SCs)
- Grant Confirmation
- UNDP-Global Fund Grant Regulations
-
Monitoring and Evaluation
- Differentiation Approach
- Monitoring and Evaluation Components of Funding Request
- M&E Components of Grant Implementation
- Monitoring and Evaluation Components of Grant Making
- Overview
- Principal Recipient Start-Up
-
Health Product Management
- Compliance with the Global Fund requirements
- Distribution
- Inspection and Receipt
- International freight, transit requirements and use of INCOTERMS
- Inventory Management
- Overview - Health Product Management
- Pharmacovigilance
- Product Selection
- Quality monitoring of health products
- Quantification and Forecasting
- Rational use
- Risk Management for PSM of health products
-
Sourcing and regulatory aspects
- Development of List of Health Products
- Development of the Health Procurement Action Plan (HPAP)
- Global Health Procurement Center (GHPC)
- Guidance on donations of health products
- Health Procurement Architecture
- Local Procurement of health products
- Other Elements of the UNDP Procurement Architecture
- Procurement of non-pharmaceutical Health Products
- Procurement of Pharmaceutical Products
- Submission of GHPC CO Procurement Request Form
- Storage
- Supply Planning of Health Products
- UNDP Health PSM Roster
- Waste management
- Grant Reporting
-
Risk Management
- Introduction to Risk Management
- Overview
- Risk management in crisis settings
-
Risk Management in the Global Fund
- Additional Safeguard Policy
- Challenging Operating Environment (COE) Policy
- Global Fund Review of Risk Management During Grant Implementation
- Global Fund Risk Management Framework
- Global Fund Risk Management Requirements During Funding Request
- Global Fund Risk Management Requirements for PRs
- Local Fund Agent
- Risk management in UNDP
- Risk Management in UNDP-managed Global Fund projects
- UNDP Risk Management Process
- Sub-Recipient Management
Inspection and Receipt
When receiving shipments of health products, the following verifications should be carried out by UNDP CO (and a national reception committee, if applicable):
- Visual inspection: Containers and products should be visually inspected for possible contamination, tampering and damage (see Annex 2 in Guidance for UNDP Country Offices on Health Products Quality Assurance in the Supply Chain). Damage to containers and any other problems that might adversely affect the quality of the material should be recorded and investigated.
- Conformity of received items with the specifications of the purchase order: item description; item code (if applicable); strength; dosage form; packaging and labelling
- Quantities delivered versus quantities ordered
- Integrity of packages and seals
- Presence of certificates of analysis, one for each batch number received, and presence of the Certificate of Pharmaceutical Product (in WHO recommended template) if required by the NRA.
- Reading and analysis of temperature conditions during transport and transit (dataloggers’ readings) – see details further below.
- Verification of remaining shelf life (RSL) – should be “at or above” the minimum RSL agreed with the supplier.
A receiving report should be completed by UNDP CO (or the reception committee, if applicable) upon each delivery. The report and the annexes (COAs, CPPs) should be archived and kept available for retrospective controls by the PR or other relevant entities (e.g., UNDP QAS Team, NDRA). If there is national reception committee, the following entities should ideally be represented in this committee: UNDP CO, NDRA, relevant disease programme (e.g., HIV national programme for reception of ARV medicines), Central Medical Stores (CMS) or other entity in charge of central storage, and the Global Fund Principal Recipient (PR), in case UNDP CO is the procurer for another PR. GFPHST issued a Standard Operating Procedure (SOP) for Inspection and Receipt of Health Products to guide UNDP COs during these activities.
Handling of dataloggers at reception
UNDP COs are responsible to ensure that the dataloggers in the shipments are retrieved, data are read, analyzed and kept as record with the reception report.
Any significant deviation observed (temperature excursion) during transportation should be immediately reported by UNDP CO to the GHPC HPS, QAS, and HPMS focal points. The GHPC QAS team will coordinate with the supplier to obtain information on the appropriate actions to take. This could lead to the replacement of the products if the supplier’s assessment is that the quality of the products cannot be guaranteed. “Significant” deviations include:
If issues of non-conformity or quality are observed at reception:
-
UNDP COs must ensure that the rejected products are either put in quarantine (if further investigation is needed) or categorized as rejected products (if rejection is final). The supplier(s) must be informed in writing as soon as possible in order to initiate any needed investigation and/or resolve the dispute.
-
Rejected products: Stringent precautions should be taken to ensure that rejected health products cannot be used. This can be achieved through separate storage or by means of a validated computerized system. Rejected products may be destroyed or be returned to the supplier.
-
UNDP CO should obtain a written statement from the suppliers about the actions to take (destruction in the recipient country, resending of remaining quantities) and the compensation for the expenses caused.